Moffitt researchers, with patience at the forefront, tackle a difficult issue that, undetected, makes treating cancer more ...
A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently ...
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...
Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage ...
Curanex Pharmaceuticals Inc. CURX on Monday said that a recent patient case study may reinforce its strategic push into ...
PanCAN PurpleStride Chicago welcomes first time Premier Sponsor Endevica Bio, who is dedicated to advancing novel treatments ...
University of Oklahoma researcher Min Li, Ph.D., is the lead author of a new publication in Cancer Cell about cancer cachexia. Cachexia is a muscle-wasting and fat-loss condition that most often ...
Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most ...
Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results